Both nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) were associated with a reduction in death during the COVID-19 Omicron era, a large retrospective study of electronic health records ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback